Researcher to Study Cause of Cancer’s Resistance to Chemotherapy
A researcher at Van Andel Research Institute in Grand Rapids, Michigan has received a $1.3 million grant from the NIH to study how tumors develop a resistance to chemotherapy. Initially, the research will focus on colon cancer.
Researchers hope that the result of the study will lead to the development of additional screening and treatment methods for other cancers as well. Dr. MacKeigan, the grant recipient, says “if the tumors are resistant to chemotherapy, the cancer is more likely to survive long enough to spread and become more deadly.”
During the five-year study Dr. MacKeigan will assess how various enzymes contribute to determining whether tumor cells will survive during chemotherapy treatment.
Based in Grand Rapids, Michigan, Van Andel Research Institute is the research arm of VAI and is “dedicated to probing the genetic, cellular and molecular origins of cancer, Parkinson and other diseases and working to translate those findings into effective therapies.”